ROCKVILLE, MARYLAND – July 13, 2026 – The global Beta-Glucans Market, valued at USD 1.6 billion in 2025, is projected to grow from USD 1.7 billion in 2026 to USD 3.0 billion by 2036, registering a CAGR of 5.8% during the forecast period. The market continues to expand as decades of clinical evidence supporting beta-glucans' immune-modulating and cholesterol-lowering properties translate into premium consumer products across dietary supplements, functional foods, cosmetics, and clinical nutrition. Food manufacturers, nutraceutical companies, ingredient suppliers, and healthcare providers are increasingly investing in clinically validated beta-glucan formulations to meet rising demand for preventive health and scientifically backed wellness solutions.

Get detailed market forecasts, competitive benchmarking, and pricing trends:https://www.factmr.com/connectus/sample?flag=S&rep_id=14559

Key Market Highlights at a Glance

• Global market size: USD 1.6 billion in 2025, projected to reach USD 3.0 billion by 2036
• CAGR: 5.8% from 2026 to 2036
• Leading source: Yeast-derived beta-glucans with 30.0% share in 2026
• Leading functionality: Soluble beta-glucans with 45.0% share in 2026
• Leading application: Health & Dietary Supplements accounting for 40.0% share in 2026
• Fastest-growing country: Japan at 7.0% CAGR
• Report details: 170 pages with 32 tables and 93 figures

Why Is the Beta-Glucans Market Growing?

The beta-glucans market is experiencing sustained growth as consumers increasingly prioritize preventive healthcare, immune resilience, and heart health through scientifically validated nutritional ingredients. Regulatory approvals supporting cholesterol-lowering and immune health claims have significantly strengthened confidence among both manufacturers and consumers, enabling premium positioning across supplements and functional food products.

Growing healthcare awareness among ageing populations, particularly across Asia Pacific, Europe, and North America, continues to drive adoption of beta-glucan-enriched foods and dietary supplements. At the same time, expanding clinical research has reinforced the role of yeast, oat, barley, and mushroom-derived beta-glucans in immune modulation, cardiovascular health, gut wellness, and skin barrier support.

Manufacturers are investing in advanced extraction technologies, sustainable raw material sourcing, and GMP-certified production facilities to deliver high-purity beta-glucans suitable for pharmaceutical-grade supplements, hospital nutrition programs, and premium functional food applications.

"FOSHU approvals, EFSA-authorised health claims, and TGA-listed supplements are transforming beta-glucans from commodity fibre ingredients into clinically validated bioactive compounds capable of supporting premium pricing and long-term market differentiation."

— Shambhunath Jha, Principal Consultant, Fact.MR

Which Source Leads the Beta-Glucans Market?

Yeast-derived beta-glucans are expected to account for approximately 30.0% of the global market in 2026. Strong clinical validation, high purity, consistent manufacturing standards, and proven immune-support benefits continue to position yeast-derived beta-glucans as the preferred choice for pharmaceutical-grade supplements and clinical nutrition products.

Oat and barley beta-glucans continue witnessing strong adoption across functional foods and beverages due to their EFSA-approved cholesterol-lowering claims, while mushroom-derived beta-glucans gain popularity in specialty wellness and nutraceutical formulations.

Which Functionality Dominates the Market?

Soluble beta-glucans are projected to capture around 45.0% of market demand in 2026 owing to their viscosity-forming properties, clinically supported cholesterol reduction benefits, and regulatory approval across several global markets.

Food manufacturers increasingly utilize soluble beta-glucans in breakfast cereals, oat beverages, bakery products, dairy alternatives, nutritional drinks, and fortified functional foods designed to deliver heart health benefits while meeting clean-label consumer preferences.

Which Application Generates the Highest Demand?

Health & Dietary Supplements are anticipated to account for approximately 40.0% of global demand during 2026. Rising consumer awareness regarding immune health, preventive nutrition, healthy ageing, and cardiovascular wellness continues to support premium supplement launches containing clinically validated beta-glucans.

Functional foods and beverages remain another high-growth application area as manufacturers leverage regulatory-approved health claims to differentiate cereals, oat drinks, snack bars, dairy products, and bakery products in increasingly competitive retail environments.

Cosmetics and personal care companies are also expanding beta-glucan usage for skin barrier protection, hydration, anti-inflammatory benefits, and microbiome-support formulations.

Market Dynamics

Key Drivers

• Growing consumer demand for immune health supplements
• Expanding EFSA, FOSHU, Health Canada, and TGA-approved health claims
• Rising functional food and beverage fortification
• Increasing clinical nutrition adoption across hospitals
• Growing ageing population seeking preventive healthcare
• Expanding scientific evidence supporting cholesterol reduction and immune modulation

Key Restraints

• Raw material price volatility across oat and yeast supply chains
• Regulatory inconsistencies between international markets
• High investment requirements for clinical validation
• Consumer education costs regarding beta-glucan differentiation
• Premium pricing compared with conventional dietary fibres

Unlock 360° insights for strategic decision making and investment planning: https://www.factmr.com/report/beta-glucans-market

Key Trends

The market is shifting from commodity dietary fibre applications toward clinically validated bioactive ingredients supported by regulatory-approved health claims. Manufacturers are investing in high-purity yeast beta-glucans, advanced oat extraction technologies, and GMP-certified production facilities while strengthening traceability and sustainable sourcing programs. Product innovation continues across functional beverages, immune supplements, hospital nutrition, sports nutrition, cosmetics, and personalised wellness formulations. Regulatory-backed premium positioning and increasing clinical evidence are expected to remain the primary competitive differentiators throughout the forecast period.

Explore More Related Studies Published by Fact.MR Research

Egg Replacement Ingredients Market: https://www.factmr.com/report/1597/egg-replacement-ingredients-market

Egg Products Market: https://www.factmr.com/report/egg-products-market

Egg Yolk Lecithin Market: https://www.factmr.com/report/841/egg-yolk-lecithin-market

Egg White Peptide Market: https://www.factmr.com/report/731/egg-white-peptide-market

Egg White Peptide Market: https://www.factmr.com/report/731/egg-white-peptide-market

About Fact.MR

Fact.MR is a global market research and consulting firm, trusted by Fortune 500 companies and emerging businesses for reliable insights and strategic intelligence. With a presence across the U.S., UK, India, and Dubai, we deliver data-driven research and tailored consulting solutions across 30+ industries and 1,000+ markets. Backed by deep expertise and advanced analytics, Fact.MR helps organizations uncover opportunities, reduce risks, and make informed decisions for sustainable growth.

 - Contact Us -
11140 Rockville Pike, Suite 400, Rockville,
MD 20852, United States
Tel: +1 (628) 251-1583 | sales@factmr.com